| Category | BioTech |
| Employees | |
| Description | Melanoma therapeutics |
| Series A, 5/09 Sante Ventures | $25M |
Molecular Templates Inc. (MTI) is a biopharmaceutical company with a novel protein platform for the development of new therapeutics against cancer. The company has a lead compound for melanoma that is expected to enter into clinical trials in the next two years and is developing additional compounds against a variety of other cancers.
